SCHEMBL19785371

SCHEMBL19785371

CCOC(=O)c1nc(-c2cccc(Cl)c2Cl)c(C)nc1N1CCC2(CC1)CS(=O)(=O)C[C@H]2C

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 18/20 0.48
EGFR P00533 1/20 0.48
KCNH2 Q12809 1/20 0.48
CDC7 O00311 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19785372 0.92 PTPN11 (0.49) PTPN11EGFRKCNH2
SCHEMBL21115165 0.86 PTPN11 (0.40) PTPN11EGFRKCNH2CDC7DBF4
SCHEMBL25514939 0.84 PTPN11 (0.67) PTPN11EGFRKCNH2
SCHEMBL28912086 0.83 PTPN11 (0.67) PTPN11EGFRKCNH2
SCHEMBL30296171 0.83 PTPN11 (0.72) PTPN11EGFRKCNH2
SCHEMBL19785506 0.83 PTPN11 (0.72) PTPN11EGFRKCNH2
SCHEMBL30511927 0.83 PTPN11 (0.72) PTPN11EGFRKCNH2
SCHEMBL26981010 0.83 PTPN11 (0.72) PTPN11EGFRKCNH2
SCHEMBL22789584 0.81 PTPN11 (0.51) PTPN11EGFRKCNH2CDC7DBF4
SCHEMBL21115211 0.81 PTPN11 (0.50) PTPN11EGFRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484856-B1 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS REVOLUTION MEDICINES INC (US) 2023-11-15 EP disclosed
WO-2018013597-A1 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS Revolution Medicines, Inc. (US) 2018-01-18 WO disclosed